Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Perioperative Rivaroxaban Anticoagulation Strategy in Prosthetic Joint Revision Arthroplasty
ChiCTR2600125914Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rivaroxaban in venous thromboembolism (VTE) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Thrombosis incidence rate and Postoperative drainage volume. Started Jun 2026; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR2600125914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125914.